Osaic Holdings’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.41M | Buy |
1,348,416
+3,510
| +0.3% | +$11.5K | 0.01% | 1132 |
|
2025
Q1 | $4.69M | Sell |
1,344,906
-2,418
| -0.2% | -$8.44K | 0.01% | 1074 |
|
2024
Q4 | $4.41M | Sell |
1,347,324
-25,030
| -2% | -$81.8K | 0.01% | 1108 |
|
2024
Q3 | $5.28M | Buy |
1,372,354
+2,515
| +0.2% | +$9.68K | 0.01% | 1005 |
|
2024
Q2 | $4.23M | Buy |
1,369,839
+2,300
| +0.2% | +$7.11K | 0.01% | 1106 |
|
2024
Q1 | $3.53M | Hold |
1,367,539
| – | – | 0.01% | 1288 |
|
2023
Q4 | $3.42M | Sell |
1,367,539
-500
| -0% | -$1.25K | 0.01% | 1462 |
|
2023
Q3 | $2.78M | Buy |
1,368,039
+1,000
| +0.1% | +$2.03K | ﹤0.01% | 1715 |
|
2023
Q2 | $3.14M | Sell |
1,367,039
-9,484
| -0.7% | -$21.8K | 0.01% | 1505 |
|
2023
Q1 | $4.17M | Hold |
1,376,523
| – | – | 0.01% | 1285 |
|
2022
Q4 | $3.21M | Buy |
1,376,523
+12,000
| +0.9% | +$28K | 0.01% | 1399 |
|
2022
Q3 | $2.61M | Hold |
1,364,523
| – | – | 0.01% | 1433 |
|
2022
Q2 | $3.7M | Sell |
1,364,523
-1
| -0% | -$3 | 0.01% | 1240 |
|
2022
Q1 | $4.07M | Sell |
1,364,524
-370
| -0% | -$1.1K | 0.01% | 1355 |
|
2021
Q4 | $5.31M | Buy |
1,364,894
+330
| +0% | +$1.28K | 0.01% | 1063 |
|
2021
Q3 | $5.85M | Sell |
1,364,564
-5,125
| -0.4% | -$22K | 0.01% | 963 |
|
2021
Q2 | $4.15M | Sell |
1,369,689
-400
| -0% | -$1.21K | 0.01% | 1152 |
|
2021
Q1 | $4.56M | Sell |
1,370,089
-1,000
| -0.1% | -$3.33K | 0.01% | 1016 |
|
2020
Q4 | $4.87M | Buy |
1,371,089
+10,800
| +0.8% | +$38.3K | 0.01% | 895 |
|
2020
Q3 | $4.26M | Sell |
1,360,289
-414,646
| -23% | -$1.3M | 0.01% | 854 |
|
2020
Q2 | $3.23M | Buy |
1,774,935
+20
| +0% | +$36 | 0.01% | 944 |
|
2020
Q1 | $1.79M | Buy |
+1,774,915
| New | +$1.79M | 0.01% | 1128 |
|